CD5+B cells: Differential capping and modulation of IgM and CD5

Scandinavian Journal of Immunology

Volumn 43, Issue 1, 1996, Pages 73-80

  Jamin, C ^a   Lydyard, P M ^b   Le Corre, R ^a   Youinou, P Y ^a  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 4BETA PHORBOL; CD5 ANTIGEN; CD72 ANTIGEN; COLCHICINE; CYCLOHEXIMIDE; CYTOCHALASIN B; CYTOCHALASIN D; DACTINOMYCIN; GENISTEIN; HERBYMICIN A; IMMUNOGLOBULIN M; LYMPHOCYTE ANTIGEN RECEPTOR; MEZEREIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN TYROSINE KINASE; STAUROSPORINE; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CAPPING PHENOMENON; CHILD; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TONSIL CELL;

EID: 0030063085     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-8.x     Document Type: Article

References (39)

1. Kantor AB. A new nomemelature for B cells. Immunol Today 1991;12:388-91.
2. Hayakawa K, Hardy RR, Honda M, Herzenberg LA, Steinberg AD, Herzenberg LA. Ly-I B cells, functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA 1984;81:2494-8.
3. + B-cell subset. Science 1987; 236:77-81.
4. - cord blood B cells. Scand J Immunol 1991;33:329-35.
5. - B cell subsets to T cell-independent mitogens. Eur J Immunol 1991;21:351-9.
6. + antiporter has different properties in human B lymphocytes according to CD5 expression and malignant phenotype. Eur J Immunol 1991;21: 583-8.
7. - B cell subsets activated through their antigen receptors or CD40 antigens. Eur J Immunol 1992;22:2831-9.
8. Spertini F, Stohl W, Ramesh N, Moody C, Geha RS. Induction of human T cell proliferation by a monoclonal antibody to CD5. J Immunol 1991;146:47-52.
9. Van den Berghe P, Ceuppens JL. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5. Eur J Immunol 1991;21:251-9.
10. Werner-Favre C, Vischer TL, Wohlwend D, Zubler RH. Cell surface antigen CD5 is a marker for activated human B cells. Eur J Immunol 1989;19:1209-13.
11. + B cells. Blood 1989; 73:202-8.
12. Pesando JM, Bouchard LS, McMaster BE. CD19 is functionally and physically associated with surface immunoglobulin. J Exp Med 1989;170:2159-64.
13. Peaker CJG, Peaker CJG, Neuberger MS. Association of CD22 with the B cell antigen receptor. Eur J Immunol 1993;23:1358-63.
14. Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992; 256:105-7.
15. Pezutto A, Rabinovitch PS, Dorken B, Moldenhauer, G, Clark EA. Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin. J Immunol 1988:140:1791-5.
16. Lankester AC, van Schijndel GMW, Cordell JL, van Noesel CJM, van Lier RAW. CD5 is associated with the human B cell antigen receptor complex. Eur J Immunol 1994;24:812-16.
17. Gold MR, Defranco AL. Biochemistry of B lymphocyte activation. Adv Immunol 1994;55:221-95.
18. Taylor RB, Duffus WPH, Raff MC, de Petris S. Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody. Nature New Biol 1971;233:225-9.
19. Thomas Y, Glickman E, DeMartino J, Wang J, Goldstein G, Chess L. Biologic function of the OKT1 T cell surface antigen. I. The T1 molecule is involved in helper function. J Immunol 1984; 133:724-8.
20. Alberola-Ila J, Places L, Fabregat V, Vives J, Lozano F. Different mechanisms regulate the monoclonal antibody-induced modulation of CD2, CD3 and CD5 in human lymphocytes. Cell Immunol 1993;147:247-55.
21. Lane PJL, Ledbetter JA, McConnell FM et al. The role of tyrosine phosphorylation in signal transduction through surface Ig in human B cells. J Immunol 1991;146:715-22.
22. Osman N, Lazarovits AI, Crumpton MJ. Physical association of CD5 and the T cell receptor/CD3 antigen complex on the surface of human T lymphocytes. Eur J Immunol 1993;23:1173-6.
23. Lavabre-Bertrand T, Janossy G, Exbrayat C, Bourquard P, Duperray C, Navarro M. Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 overexpression and monitoring in B-CLL. Leukemia 1994;8:1557-63.
24. June CH, Rabonivitch PS, Ledbetter JA. CD5 antibodies increase intracellular ionized calcium concentration in T cells. J Immunol 1987;138:2782-92.
25. Alberola-Ila J, Places L, Cantrell DA, Vives J, Lozano F. Intracellular events involved in CD5-induced human T cell activation and proliferation. J Immunol 1992;148:1287-93.
26. Lydyard PM, MacKenzie L. Lymphocyte activation by CD5 mAb. In: Knapp W, Dörken B, Gilk WR et al., eds. Leucocyte Typing IV, White Cell Differentiation Antigens. Oxford: Oxford University Press, 1989: 338-9.
27. Akiyama T, Ishida J, Nakagawa S et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262:5592-5.
28. Davies A, Ley SC, Crumpton MJ. CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex. Proc Natl Acad Sci USA 1992;89:6368-72.
29. fyn. Proc Natl Acad Sci USA 1992;89:9311-15.
30. Alberola-Ila J, Places L, Lozano F, Vives J. Association of an activation inducible serine kinase activity with CD5. J Immunol 1993;151:4423-30.
31. Jamin C, Dueymes M, Lydyard PM, Youinou P. Anti-CD5 sustains proliferative response of IgM-activated human CD5-positive B cells. Scand J Immunol 1995;42:282-5.
32. Tarakhovsky A, Müller W, Rajewsky K. Lymphocyte populations and immune responses in CD5-deficient mice. Eur J Immunol 1994;24:1678-84.
33. Tarakhovsky A, Kanner SB, Hombach J et al. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 1995;269:535-7.
34. Jamin C, Magadur G, Lamour A et al. Cell-free CD5 in patients with rheumatic diseases. Immunol Letters 1991;31:79-84.
35. Puré E, Tardelli L. Tyrosine phosphorylation is required for ligand-induced internalization of the antigen receptor on B lymphocytes. Proc Natl Acad Sci USA 1992;89:114-17.
36. Braun J, Hochman PS, Unanue ER. Ligand-induced association of surface immunoglobulin with the detergent-insoluble cytoskeletal matrix of the B lymphocyte. J Immunol 1982;128:1198-204.
37. Ledbetter JA, Martin PJ, Spooner CE et al. Antibodies to Tp67 and Tp44 augment and sustain proliferative response of activated T cells. J Immunol 1985;135:2331-6.
38. Ceuppens JL, Baroja ML. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase bound OKT3. J Immunol 1986;137:1816-21.
39. van de Velde H, von Hoegen I, Luo W, Parnes JA, Thielemans K. The B cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 1991;351:662-4.